Clinical and immunological predictors of SARS-CoV-2 infection and Covid-19 diseases in patients with renal diseases and healthy persons

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021297

Enrollment

100

Registered

2020-05-04

Start date

2020-04-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J06.9 U07.1

Interventions

Group 1: Renal disease Immunological Response on SARS-CoV-2 infection will be analyzed, e.g. lymphocyte sub-Population.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Age 18 and older • existing Information on o demographics o renal function o clinical events • possibility to understand the study and sign the declaration of consent • signature on the consent sheet

Exclusion criteria

Exclusion criteria: missing consent

Design outcomes

Primary

Measure	Time frame
incidence of a severe COVID-19 infection (hospitalized in an intensive care unit)	—

Secondary

Measure	Time frame
Change in subsets of lymphocytes	—

Countries

Germany

Contacts

Public ContactClaudia Sommerer

Sektion NephrologieMedizinische Universitätsklinik Heidelberg

info@nierenzentrum-heidelberg.com06221 91120

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026